⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 5, 2024Circulation ReportsOpen Access

One-Month Dual Antiplatelet Therapy in High Bleeding Risk Asian Patients Undergoing Percutaneous Coronary Intervention ― Onyx ONE Clear 2-Year Results ―

Jeehoon Kang Azimah Abdul Ghapar Kamaraj Selvaraj Seung‐Ho Hur Chor Cheung Tam Yangsoo Jang In‐Ho Chae David E. Kandzari Ajay J. Kirtane Azeem Latib Elvin Kedhi Te-Hsin Lung So-Jeong You Stephan Windecker Gregg W. Stone Hyo‐Soo Kim

View Full Paper

Ask AI

Bookmark

Share

Abstract

One-month dual antiplatelet therapy (DAPT) in high bleeding risk (HBR) patients undergoing percutaneous coronary intervention (PCI)

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kang et al. (2024) studied this question.

synapsesocial.com/papers/68e613c8b6db6435875a6c5e https://doi.org/10.1253/circrep.cr-24-0037

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patientscohort · 2020 · 67 citations
2Short dual antiplatelet therapy after PCI with Resolute Onyx drug-eluting stents in high bleeding risk patients: One-year outcomes from a South Asian cohortcohort · 2025
3Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapyRCT · 2019 · 35 citations
4Sex-Based Outcomes in Patients With High Bleeding Risk After PCI With 1-Month DAPT: Results From the Onyx ONE Clear Trialcohort · 2026
5Sex-Based Outcomes in Patients With High Bleeding Risk After PCI With 1-Month DAPT: Results From the Onyx ONE Clear Study.cohort · 2026

More related papers

Two-Year Clinical Outcomes in Patients With Coronary Bifurcation Lesions: Results From the Onyx ONE Clear Study2026
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes2024
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI2021

More from Circulation Reports

Short-Term Cost–Utility Analysis of Once-Weekly Supervised Outpatient Cardiac Rehabilitation ― A Single-Center Retrospective Cohort Study Using a Hypothetical Nonparticipation Scenario ―Thu,
Low-Density Lipoprotein Cholesterol Target Achievement Rates in Japanese Patients With Dyslipidemia ― Retrospective Analyses of a Nationwide Clinical Database ―Mon,